Latest News - Corporate Lawsuits

Monday, September 18, 2017 | Corporate Lawsuits, Patents, Allergan

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan caused a lot of hand-wringing in the biotech community and excitement among patent lawyers, when the drugmaker announced it would transfer patents for Restasis, Allergan's longstandi…

Read the full story

Monday, September 11, 2017 | Corporate Lawsuits, Imprimis Pharmaceuticals

Imprimis Releases Statement Regarding Allergan Lawsuit

Imprimis Pharmaceuticals responded to a press release issued by Allergan regarding a lawsuit Allergan USA filed against Imprimis. A portion of the Imprimis statement reads: "Imprimis will aggr…

Read the full story

Friday, September 08, 2017 | Corporate Lawsuits, Allergan

Allergan Files Suits Against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida

Allergan USA has filed lawsuits against Imprimis Pharmaceuticals, Prescriber's Choice, and Sincerus Florida, alleging that those companies are unlawfully manufacturing and selling unapproved new d…

Read the full story

Tuesday, August 22, 2017 | Corporate Lawsuits, Sightpath Medical

Minneapolis Eye Surgery Company Will Pay $12 Million in Alleged Kickbacks Case

A Minneapolis mobile ophthalmic company and its former CEO have agreed to pay $12 million to resolve allegations that it lured physicians with illegal kickbacks in exchange for their business for near…

Read the full story

Thursday, August 10, 2017 | Corporate Lawsuits, Patents, PhysIOL sa

PhysIOL: Company Successful in Patent Infringement Action Protecting FINEVISION IOLs

PhysIOL has claimed that the Dusseldorf District Court in Germany has confirmed that VSY Biotechnology infringes the European Patent EP 2 503 962 of PhysIOL S.A. In its judgment on June 29, 2017, the …

Read the full story

Sunday, July 02, 2017 | Corporate Lawsuits, Allergan

Allergan Settles Whistle-Blower Lawsuit

Allergan settled a whistle-blower lawsuit brought by two Philadelphia-area ophthalmologists who alleged the company provided paid speaking engagements, free business consulting, and other services as …

Read the full story

Wednesday, April 19, 2017 | Corporate Lawsuits, Allergan

Allergan, Argentum Settle Patent Dispute Over Restasis

U.S. generic drug company Argentum Pharmaceuticals LLC said on Tuesday it had reached an agreement with Allergan Plc that settles a patent dispute over the generic version of Allergan's eye drug, …

Read the full story

Thursday, March 30, 2017 | Corporate Lawsuits

Carl Zeiss Meditec Wins Patent Infringement Action on Trifocal IOL; VSY to Appeal Decision

Carl Zeiss Meditec has won a patent infringement action before the District Court of Düsseldorf/Germany against VSY Biotechnology BV and its exclusive supplier Fritz Ruck Ophthalmologische System…

Read the full story

Tuesday, March 28, 2017 | Corporate Lawsuits, Valeant

Former Valeant CEO Michael Pearson Sues Company Over Unpaid Share Award

Former Valeant Pharmaceuticals CEO Michael Pearson filed a lawsuit in the US claiming that the company failed to deliver 3 million shares promised to him as part of an exit package. According to the c…

Read the full story

Tuesday, January 17, 2017 | Corporate Lawsuits, Bausch+Lomb

Bausch + Lomb Successfully Defends Patent Covering PreserVision Eye Vitamins in Case vs. Vitamin Health Inc.

Bausch + Lomb announced it has resolved its patent infringement lawsuit vs. Vitamin Health, filed in September 2013 in the U.S. District Court for the Western District of New York. Among other claims,…

Read the full story

Friday, December 16, 2016 | Corporate Lawsuits

U.S. Says Allergan's Forest Units to Pay $38 Million to Settle Kickback Allegations

Allergan PLC's Forest Laboratories and Forest Pharmaceuticals units will pay $38 million to settle U.S. charges that it paid physicians to prescribe three medications, the U.S. Justice Department …

Read the full story

Friday, October 30, 2015 | Corporate Lawsuits, Glaukos Corporation, Transcend Medical

Glaukos Announces Settlement of Patent Litigation with Transcend Medical

Glaukos announced that it has entered into a settlement agreement with Transcend Medical to resolve all existing patent litigation between the two companies, according to a company news release. Un…

Read the full story

Thursday, September 24, 2015 | Corporate Lawsuits

App Maker Settles With the Feds Over Charges of Improper Marketing of Vision Improvement Program

The Federal Trade Commission cracked down on Carrot Neurotechnology for making apparently unfounded claims that its Ultimeyes app is "scientifically shown to improve vision." The company agr…

Read the full story

Tuesday, September 22, 2015 | Corporate Lawsuits, Glaukos Corporation, Transcend Medical

District Court Rules on Summary Judgment Motions in Glaukos Patent Litigation with Transcend Medical

The United States District Court for the District of Delaware issued rulings on three pending summary judgment motions in Glaukos’s patent lawsuit with Transcend Medical related to Transcend&rsq…

Read the full story

Thursday, September 03, 2015 | Corporate Lawsuits, InSite Vision

InSite Vision Named in BromSite Patent Lawsuit; Company Believes Lawsuit Is Without Merit

InSite Vision announced that Johnson Matthey Pharmaceutical Materials has filed a patent lawsuit in the United States District Court for the District of Delaware in connection with activities relating…

Read the full story
Load More